Related Experiment Video
Updated: Jul 5, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Stenting of the Patent Ductus Arteriosus
Katherine Price1, Justin R Ryan2, Howaida El-Said3
1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnett Avenue, Cincinnati, OH, USA.
Insights
PDA stenting has evolved significantly, offering improved outcomes for infants with duct-dependent pulmonary circulation. This technique is also used for pulmonary arterial hypertension and hybrid procedures, with ongoing advancements.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Interventional Cardiology
Background:
- Patent ductus arteriosus (PDA) stenting has evolved since the 1990s.
- Technical advancements have led to improved outcomes.
- Some centers now exclusively use PDA stenting for duct-dependent pulmonary circulation.
Purpose of the Study:
- Review indications and outcomes for PDA stenting.
- Describe the PDA stenting procedure.
- Discuss future directions in PDA stenting.
Main Methods:
- Review of existing literature and clinical data on PDA stenting.
- Description of the technical aspects of the PDA stenting procedure.
- Analysis of outcomes in various patient populations.
Main Results:
- PDA stenting has demonstrated improved outcomes in infants with duct-dependent pulmonary circulation.
- The procedure has been adapted for palliative treatment of suprasystemic pulmonary arterial hypertension.
- PDA stenting is a component of the hybrid procedure.
Conclusions:
- PDA stenting is a valuable intervention with expanding applications.
- Continued technical advancements are expected to further enhance outcomes.
- Future research should focus on long-term results and novel applications.
Abstract:
Since PDA stenting was first attempted in the early 1990s, significant technical advancements have improved outcomes and some centers have even transitioned to exclusive PDA stenting for all infants with duct-dependent pulmonary circulation. In addition to its use in infants with duct-dependent pulmonary circulation, PDA stenting has also been adapted as a percutaneous palliative option for suprasystemic pulmonary arterial hypertension and as a component of the hybrid procedure. In this article, the authors aim to review indications and outcomes for PDA stenting, describe the procedure, and discuss future directions.

